Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 September 2021 | Story Marius Coetzee and Rulanzen Martin | Photo Supplied
From the left: Werner Stolze of Stolze Pianos (sponsor), Karlin Kock (Trio Con Brio), Dr Mageshen Naidoo (adjudicator – UP), Kagiso Ramosa (Trio Con Brio), Renette Bouwer (adjudicator – UJ), Maria Yasbeck (Trio Con Brio), and Prof Wessel van Wyk from UP.

The Trio Con Brio ensemble in the Odeion School of Music (OSM) was crowned winners of the open category during the final round of the national SASMT Ensemble competition, which took place on 22 September 2021.  The Trio Con Brio comprises OSM students Kagiso Ramosa (clarinet), Maria Yasbeck (violin), and Karlin Kock (piano).

OSM lecturers, Drs Danre Strydom, Sharon de Kock, and Anneke Lamont served as instructors and mentors during the preparation phase. “The trio prepared their concert programme with an interesting methodology, by having weekly instruction from all lecturers individually on a rotation basis,” says Marius Coetzee, Artistic Director of the Odeion School of Music Camerata (OSMC). Elsabé Raath serves as the principal instructor. 

The OSMC took second place in the concert programme, while the instructor of the OSM Brass Quintet, George Foster, and the convenor, Quinn Kakora, were also selected to participate in the first round of the competition. Their recital was highly ranked and came third in the first round.

 SASMT competition develops young musicians 

The first SASMT Pretoria Ensemble Competition took place in September 2017. It would be the first competition of this nature to be held in the northern region of South Africa. The goal was to create an opportunity for young musicians to compete in groups, rather than focusing on solo performances. The feedback from the initial competition was overwhelmingly positive, culminating in the decision to make it an annual event.

The competition aims to develop young musicians through collaborative participation and by encouraging the enjoyment of performing with others. Another objective is to foster understanding, love, and appreciation for ensemble music and the performance thereof among young musicians. 

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept